Danaher CEO to Present at TD Cowen Health Conference

Live webcast will carry Rainer M. Blair's presentation from Boston on March 3.

Published on Feb. 24, 2026

Got story updates? Submit your updates here. ›

Danaher Corporation, a leading global life sciences and diagnostics innovator, announced that President and Chief Executive Officer Rainer M. Blair will be presenting at the TD Cowen Healthcare Conference in Boston, Massachusetts on Tuesday, March 3, 2025 at 1:50 p.m. ET. The event will be simultaneously webcast and can be accessed on Danaher's investor website.

Why it matters

Danaher is a major player in the life sciences and diagnostics industry, and its CEO's participation in high-profile industry conferences like the TD Cowen Healthcare Conference is an important signal of the company's strategic priorities and growth outlook.

The details

Danaher's presentation at the TD Cowen Healthcare Conference will provide investors and industry analysts with an opportunity to hear directly from the company's top executive about its latest innovations, market positioning, and financial performance. The live webcast will allow a wider audience to tune in and assess Danaher's trajectory.

  • Danaher's CEO Rainer M. Blair will present at the TD Cowen Healthcare Conference on Tuesday, March 3, 2025 at 1:50 p.m. ET.

The players

Danaher Corporation

A leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health.

Rainer M. Blair

The President and Chief Executive Officer of Danaher Corporation.

TD Cowen Healthcare Conference

A prominent industry event that brings together healthcare companies, investors, and analysts.

Got photos? Submit your photos here. ›

What’s next

Investors and industry analysts will be able to access the live webcast of Rainer M. Blair's presentation on Danaher's investor website on March 3, 2025.

The takeaway

Danaher's participation in the TD Cowen Healthcare Conference underscores the company's commitment to engaging with the investment community and showcasing its leadership in the life sciences and diagnostics sectors.